Market Trends of Global Diabetic Retinopathy Industry
This section covers the major market trends shaping the Diabetic Retinopathy Market according to our research experts:
Proliferative diabetic retinopathy is Expected to Hold Significant Market Share in the Type Segment
Proliferative diabetic retinopathy (PDR) is the most advanced stage of diabetic retinopathy. At this stage, circulation problems deprive the retina of oxygen. As a result, new, fragile blood vessels can begin to grow in the retina and into the vitreous, the gel-like fluid that fills the back of the eye. The new blood vessels may leak blood into the vitreous, clouding vision.
Symptoms include progressive loss of vision, particularly in those who are not properly followed or treated. The major risk factors for PDR include the duration of diabetes. Hence, the rising prevalence of diabetes is directly contributing to a further increase in the prevalence of PDR.
The rising research and development activities for developing effective diagnostic and therapeutic methods for proliferative diabetic retinopathy will further drive the segment growth. For instance, "Mi-RNA-93 and Mi-RNA-152 in the Diagnosis of Type 2 Diabetes and Diabetic Retinopathy" published in January 2022, MiR-93 and miR-152 can differentiate between patients with diabetes and those with diabetic retinopathy. Both miRNAs can be potential biomarkers for diabetes and diabetic retinopathy, and specifically for proliferative diabetic retinopathy.
Additionally, the study "Vitreous Inflammatory Cytokines and Chemokines, Not Altered After Preoperative Adjunctive Conbercept Injection, but Associated With Early Postoperative Macular Edema in Patients With Proliferative Diabetic Retinopathy" published in March 2022, preoperative adjunctive anti-VEGF drug (Conbercept) on vitreous inflammatory cytokines and chemokines profiles and cytokines were associated with early macular edema (ME) after surgery for patients with proliferative diabetic retinopathy (PDR). Thus, studies proving the efficacies to existing treatments will further increase its adoption, thus driving the market.
Thus, due to the above-mentioned factors, the studied segment is expected to drive the segment growth during study period.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to be significantly driven during the study period owing to the factors such as the rising prevalence of diabetes and blindness , the growing geriatric population, and increasing technological advancements in diabetic retinopathy surgical instruments.
Over the past decade, the prevalence of diabetes in North America has increased. People with diabetes are at risk for diabetic retinopathy. Diabetic retinopathy is the leading cause of new cases of blindness among adults aged 20 to 74 years in the United States. According to the data published by the Centers for Disease Control and Prevention (CDC) in 2020 around 4.1 million Americans are affected with diabetic retinopathy, and nearly 900,000 Americans are threatened with vision-damaging retinopathy. Hence the increasing number of people living with diabetic retinopathy is expected to contribute to market growth across the country.
In December 2021, the Tec's system for early detection of Diabetic Retinopathy assisted by Artificial Intelligence (DRAI) was included in the 30 projects with potential to contribute to the Global Partnership on Artificial Intelligence (GPAI). Diabetic retinopathy is damage caused by the disease to small blood vessels in the retina's light-sensitive tissue. It is one of the most common causes of blindness. DRAI tackles 3 diabetic retinopathy problems in Mexico which are high rates of diabetes, lack of ophthalmologists (42.5 ophthalmologists per 1 million people) and few early detection program. Providing solutions for all three primary issues prevalent in the country the inclusion of Tec system will likely to boost the growth of the market in coming future.
Awareness is one of the key issues related with diabetic retinopathy treatment and diagnostics. For instance, in December 2021 a paper published in National Library of Medicine "Prevalence of and Factors Associated with Diabetic Retinopathy in Patients with Diabetes Mellitus at Siriraj Hospital - Thailand's Largest National Tertiary Referral Center" stated that there is no conclusive study that proves direct correlation between people suffering from diabetic retinopathy and going for continuous eye screening. Early detection is one of the factors that could provide the treatment for the patients suffering from diabetic retinopathy disorders at an early stage.
Thus, due to the above-mentioned factors, the North American region is expected to be significantly driven during the study period.
